4//SEC Filing
Doyle Noah 4
Accession 0001382963-17-000168
CIK 0001460702other
Filed
Oct 26, 8:00 PM ET
Accepted
Oct 27, 1:53 PM ET
Size
9.5 KB
Accession
0001382963-17-000168
Insider Transaction Report
Form 4
Doyle Noah
Director
Transactions
- Purchase
Warrants (right to buy)
2017-10-03+5,000,000→ 5,000,000 total(indirect: by Javelin Venture Partners, L.P.)Exercise: $0.44From: 2017-10-03Exp: 2022-10-03→ Common Stock (5,000,000 underlying) - Purchase
Common Stock
2017-10-03+5,000,000→ 7,047,804 total(indirect: by Javelin Venture Partners, L.P.)
Holdings
- 322,753(indirect: By LLC)
Common Stock
- 22,727
Common Stock
Footnotes (3)
- [F1]Javelin Venture Partners, L.P. ("Javelin") purchased 5,000,000 Class A Units of the Issuer, consisting of 5,000,000 shares of common stock and warrants to purchase 5,000,000 shares of common stock, in the Issuer's October 2017 public offering at the public offering price of $0.40 per Class A Unit. The shares of common stock and warrants that are part of the Class A Units sold to Javelin in the puble offering were immediately separable and were issued separately in the offering.
- [F2]As the managing director of Javelin, the Reporting Person may be deemed the beneficial owner of the securities sold to Javelin in the public offering. The Reporting Person expressly disclaims beneficial ownership over these securities except to the extent of his pecuniary interest therein.
- [F3]As the managing director of Javelin Venture Partners I SPV I LLC. the Reporting Person may be deemed the beneficial owner of these shares. The Reporting Person expressly disclaims beneficial ownership over these shares except to the extent of his pecuniary interest therein.
Documents
Issuer
RITTER PHARMACEUTICALS INC
CIK 0001460702
Entity typeother
Related Parties
1- filerCIK 0001631673
Filing Metadata
- Form type
- 4
- Filed
- Oct 26, 8:00 PM ET
- Accepted
- Oct 27, 1:53 PM ET
- Size
- 9.5 KB